Search Results
Keyword:DOME
India plans to build at least five domestically designed small modular reactors by 2033, and reports on nuclear power plant safety assessments
In a written reply to the Lok Sabha on August 12, Jitendra Singh, India's Minister of State for Atomic Energy, stated that a key objective of the Indian government under its nuclear energy mission is to develop and operationalize at least five domestically designed small modular reactors by 2033. According to the briefing, the Bhabha Atomic Research Centre (BARC) is advancing the design and development of indigenous small modular reactor (SMR) technology, with projects including the 220 MWe Bharat Small Modular Reactor (BSMR-200) and the 55 MWe SMR-55 for power generation. BARC is also developing a High-Temperature Gas-Cooled Reactor (HTGCR) with a capacity of up to 5 MW, which can be coupled with suitable thermochemical cycles for hydrogen production. Singh stated that India...
2026-08-13
Completion of World's First Domestic CAP1000 50Hz Canned Motor Reactor Coolant Pump for Guangdong Lianjiang Nuclear Power Phase I
Recently, the world's first domestically manufactured CAP1000 50Hz canned motor reactor coolant pump for the Guangdong Lianjiang Nuclear Power Phase I project was successfully completed and ready for shipment. The completion of this equipment marks significant new progress in the independent development and localization of China's Generation III nuclear power core equipment. Harbin Electric Group provided the canned motor for this reactor coolant pump. The Guangdong Lianjiang Nuclear Power Phase I project plans to construct two domestically developed CAP1000 Generation III passive pressurized water reactor units, each with a single-unit capacity of 1.25 million kilowatts. The project is based on the independent CAP1000 Generation III passive nuclear power technology, adopts a seawater secondary circulation cooling scheme, promotes the coordinated development of nuclear power development and coastal ecological protection, and serves the green and low-carbon development needs of the Guangdong-Hong Kong-Macao Greater Bay Area. This...
2026-08-13
Leshan Accelerates Construction of Medical Isotope Production Base to Promote Domestic Substitution of "Anti-Cancer Nuclear Drugs"
On August 11, at the Leshan special press conference of "Myriad Scenes in Sichuan · Embarking on the '15th Five-Year Plan'", Leshan Mayor Zhao Yingchun stated that Leshan is accelerating the construction of the largest and most comprehensive medical isotope production base in China. Upon completion, the project will help break the foreign monopoly and import dependence on related products, promote the domestic substitution of anti-cancer nuclear drugs, and enable more patients to access domestically produced drugs with lower prices and better efficacy. Zhao Yingchun noted that during the "14th Five-Year Plan" period, Leshan has focused on building the "China Green Silicon Valley", a world-class tourist destination, and a major regional transportation and logistics hub in the province, continuously promoting high-quality development, with its economic output surpassing 250 billion yuan...
2026-08-12
Russia's MEPhI Receives Over 1 Billion Rubles in Funding for Two Domestic Scientific Instrument Projects
The Russian Ministry of Science and Higher Education will allocate 2.81 billion rubles to support the development of eight types of domestically produced scientific research equipment. According to the results of an additional competitive selection, the funds are planned to be disbursed from 2026 to 2028, with six universities and research institutions set to receive support. Among them, the National Research Nuclear University MEPhI (Moscow Engineering Physics Institute) will receive the largest share, with two projects totaling slightly over 1 billion rubles in funding. Under the arrangement, MEPhI will receive 591 million rubles for the development of a tandem quadrupole time-of-flight mass spectrometer (QTOF MS), and an additional 433 million rubles for the atom probe tomography project. Both projects have previously been approved by the Russian Academy of Sciences and included in...
2026-08-12
Russia's First Domestic 3D Scanner Helix Included in National Product Registry, Rosatom Completes Additive Manufacturing Technology Chain
The Russian Ministry of Industry and Trade has included the first domestically produced 3D scanner, the RangeVision Helix, in the Unified Register of Russian Electronic Products and the confirmed register of Russian-made industrial products. The registration was carried out in accordance with Russian Government Resolutions No. 878 and No. 719. Thus, the Helix has become the first and currently the only 3D scanner in Russia to be included in the aforementioned national registers. The RangeVision Helix was developed and manufactured by RangeVision, an additive manufacturing partner of Rosatom. Since 2025, the company has become the only Russian 3D scanner manufacturer included in Rosatom's additive manufacturing ecosystem...
2026-08-08
First Clinical Treatment Successfully Completed with China's Domestic Superconducting Cyclotron Proton Therapy System by CYC-Ion
On the morning of August 7, the domestically developed superconducting cyclotron proton therapy system, independently developed by Hefei CYC-Ion Medical Technology Equipment Co., Ltd., completed the first clinical trial treatment of a subject at Hefei Ion Medical Center. This marks a significant breakthrough as the first domestically produced superconducting cyclotron proton radiation therapy system in China. The subject in this case was a lung cancer patient. The superconducting proton therapy system used in the trial is equipped with the SC240 superconducting cyclotron independently developed by CYC-Ion, featuring an ultra-large irradiation field and 360° full-angle beam delivery capability. The entire treatment process relied on multi-modal fusion 4D image-guided precise positioning, enabling dynamic adaptation and precise treatment. The equipment operated smoothly with low noise, and the treatment control software ran...
2026-08-07
South Korea Advances First Domestic Commercial Production of Lu-177 Using Wolsong Heavy Water Reactors
Korea Hydro & Nuclear Power (KHNP) plans to use the heavy water reactors at the Wolsong Nuclear Power Plant to produce, for the first time domestically, the radioisotope lutetium-177 (Lu-177) for cancer treatment. Currently, South Korea relies entirely on imports for this material, which imposes cost pressures and supply instability on local radiopharmaceutical companies such as Cellbion and FutureChem. Industry experts generally believe that domestic production will help build a diversified supply chain and shorten transportation times. The primary goal of this plan is to achieve commercial production of Lu-177, with pilot production expected in 2028 and full-scale production commencing in 2031. Subsequently, KHNP will expand production to include cobalt...
2026-08-06
Czech nuclear safety officials say domestic nuclear power plants have sufficient cooling water for both existing and new units
Droughts across parts of Europe are affecting the operation of some nuclear power plants. Due to low water levels and flow rates in the Danube River, two reactors at Romania's Cernavodă Nuclear Power Plant have been shut down, and Hungary's Paks Nuclear Power Plant also faces the risk of a complete shutdown. Štěpán Kochánek, Chairman of the Czech State Office for Nuclear Safety (SÚJB), stated that plant operators should not be allowed to continue operating units at full power when cooling water is insufficient, and that related shutdown measures are conservative actions predefined in operating procedures. Kochánek explained that reactor shutdowns are not an unusually rare operation. Unit shutdown typically involves gradually reducing reactor power, inserting control rods, and bringing fission reactions to a minimal level or complete cessation. After shutdown, the reactor still requires cooling, but the demand for cooling water volume and capacity is significantly lower than during full-power operation. He noted that this process shares similarities with planned outages such as refueling overhauls and is a standardized procedure that operators should master.
2026-08-05
Zhang Yiming, Chairman of HTA: Tackling the "Last Mile" of Nuclear Pharmacy Network Delivery to Bring Domestic Radiopharmaceuticals to Patients in Western and County-Level Regions
On July 28, the 2026 Radiopharmaceutical Innovation and Development Conference was held in Taiyuan, Shanxi Province. Zhang Yiming, Party Committee Secretary and Chairman of HTA, told reporters that the company is restructuring its short half-life radiopharmaceutical delivery system through "regional layout + standardized logistics + grassroots empowerment," striving to ensure that cancer patients in western and county-level regions can access domestically produced radiopharmaceuticals within the drug's effective half-life window. Currently, multi-dimensional policy dividends are being continuously released, and China's radiopharmaceutical industry is entering a critical window of opportunity. Alpha nuclide drugs represent the future direction of therapeutic radiopharmaceuticals. Zhang Yiming introduced that HTA has already made early arrangements for drug research in this field, jointly conducting research on actinium-225 labeled...
2026-08-05
Russia Plans to Complete Domestic MRI Scanner Development by 2027
On August 1, Russian Prime Minister Mikhail Mishustin stated that Russia should complete the development of a domestically produced MRI scanner by 2027. Mishustin learned about the relevant progress during his visit to the Consultative Diagnostic Center in the Republic of Tyva. While inspecting the MRI equipment installed at the center, he asked Russian Health Minister Mikhail Murashko about the development of domestic devices. Murashko stated that the research and development work is being carried out by Rosatom, and noted that the device is expected to be completed next year. Mishustin then expressed hope that Russia would have its own domestically developed MRI scanner next year. If the device is completed as planned, it will be used in the field of medical imaging diagnostics.
2026-08-05
Xinjiang's First Domestically Developed SPECT/CT Put into Operation at the First Affiliated Hospital of Shihezi University
Recently, the mid-term summary meeting of the National Key R&D Program project "Research on Application Solutions for Domestically Developed Dual-Head Single-Photon Imaging Equipment (SPECT)" under the 14th Five-Year Plan, along with the SPECT/CT commissioning ceremony and academic seminar, was held at the First Affiliated Hospital of Shihezi University. The Insight four-dimensional quantitative SPECT/CT from永新医疗 (Yongxin Medical) was officially installed in Xinjiang, becoming the first domestically developed SPECT/CT system put into clinical use in the region. A representative from the First Affiliated Hospital of Shihezi University stated that the commissioning of the domestically developed SPECT/CT will help the hospital improve its precision diagnosis and treatment system in northern Xinjiang and enhance regional nuclear medicine service capabilities. Experts attending the meeting noted that the deployment of this system in clinical practice will help explore the standardized application pathways of SPECT/CT in primary hospitals and accumulate clinical experience in the use of nuclear medicine imaging equipment in western China.
2026-08-03
Beijing Key Laboratory Unveiled: Focusing on Domestic Production of Liquid-Helium-Free Superconducting MRI and X-ray CT Equipment
Recently, the "Beijing Key Laboratory for Innovation and Translation of Advanced Superconducting MRI and CT Medical Equipment," spearheaded by Wandong Medical, was officially inaugurated. Previously approved by the Beijing Municipal Science &
2026-07-27